| Literature DB >> 34094859 |
Yufeng Wang1,2, Wei Zhang2,3, Qingqiang Yao1,3.
Abstract
BACKGROUD: Tissue engineering using cells, scaffolds, and bioactive molecules can promote the repair and regeneration of injured tissues. Copper is an essential element for the human body that is involved in many physiological activities and in recent years, copper has been used increasingly in tissue engineering.Entities:
Keywords: Biomaterials; Bone; Cartilage; Copper; Tissue engineering
Year: 2021 PMID: 34094859 PMCID: PMC8164005 DOI: 10.1016/j.jot.2021.03.003
Source DB: PubMed Journal: J Orthop Translat ISSN: 2214-031X Impact factor: 5.191
Fig. 1(a) Schematic diagram of cartilage defects and bone defects. (b) Schematic diagram of tissue engineering strategies.
Metal elements and their effects on human body [127].
| Element | Symbol | Atomic percent (%) | Properties |
|---|---|---|---|
| Major Elements | |||
| Sodium | Na | 0.037 | Regulation of osmotic pressure, “sodium pump” action, acid-base balance, and transmission of neural information |
| Potassium | K | 0.033 | Prosthetic groups that stabilize internal cell structure and activate certain internal enzymes |
| Magnesium | Mg | 0.007 | Internal structure stabilizers and cofactors of intracellular enzymes, assisting in DNA replication and protein biosynthesis, maintaining bone mechanical strength |
| Calcium | Ca | 0.22 | One of the main components of bones, teeth, and cell walls; maintaining the permeability of blood capillary and cytomembrane and the excitability of neuromuscular |
| Trace Elements | |||
| Iron | Fe | 6.7 × 10−4 | Hemoglobin, a component of myoglobin, aiding mitochondrial electron to transfer and oxidative phosphorylation |
| Copper | Cu | 1.04 × 10−5 | An important cofactor for cytochrome oxidases, an important cofactor for the cross-linking effect of elastic fibers and collagen in connective tissue, having an antibacterial function |
| Zinc | Zn | 3.1 × 10−4 | The main component of zincase, aiding in forming collagen and healing wounds |
| Manganese | Mn | 1.5 × 10−6 | Assisting in the synthesis of important factors such as mucopolysaccharide, lipopolysaccharide, glycoprotein, hyaluronic acid, chondroitin sulfate, and maintains the integrity of connective tissue structure and function |
| Cobalt | Co | 3.0 × 10−7 | One of the essential components of vitamin B12, stimulating the production of RBC, promoting the release of bradykinin to expand blood vessels |
| Molybdenum | Mo | 4.5 × 10−8 | Participating in the mutual reaction between sulfur, iron and copper, is the main component of molybdenum-containing enzymes |
| Chromium | Cr | 8.9 × 10−8 | Maintaining normal glucose tolerance and blood lipid metabolism |
| Tin | Sn | 6.0 × 10−7 | Promoting body growth and development |
| Vanadium | V | 1.2 × 10−8 | Large doses of vanadium can inhibit ATP hydrolase, thereby affecting the metabolism of bone and sugar |
| Nickel | Ni | 1.5 × 10−6 | Composition of Cu2 + binding site and albumin amino-terminal binding site |
Fig. 2Different formats of copper. (a) Copper simple substance; (b) Copper ions; (c) Copper oxide powders; (d) Copper alloy; (e) Copper nanoparticles.
Various copper-containing scaffolds.
| Base Materials | Copper Formats | Properties | Ref. |
|---|---|---|---|
| Mesoporous bioactive glass | copper ions | Osteogenesis, angiogenesis, antibacterial, drug loading | [ |
| Bioactive glass nanoparticles (Nbg) and alginate | copper ions | Osteogenesis, angiogenesis, cross-linking, promote the production of BMSCs, sustained release | [ |
| Boron-containing bioactive glass-based scaffolds coated with alginate | copper ions | Osteogenesis, angiogenesis | [ |
| Chitosan/hydroxyapatite composite scaffolds | copper ions | Osteogenesis, angiogenesis, antibacterial, anti-inflammatory, sustained release | [ |
| Electrospun Bioactive Glass Nanofibers | copper ions | Osteogenesis, angiogenesis, antibacterial | [ |
| mesoporous bioactive glass and nanofibrillated cellulose | copper ions | Angiogenesis | [ |
| Borosilicate glasses | copper ions | Osteogenesis, angiogenesis, sustained release, structural stability | [ |
| Alginate | copper ions | Angiogenesis, auxiliary cross-linking | [ |
| Quercetin | copper ions | Osteogenesis, angiogenesis | [ |
| Calcium phosphate | copper ions | Osteogenesis, angiogenesis, antibacterial | [ |
| Bioactive glass (BG) scaffolds | CuFeSe2 | Osteogenesis, photothermal effect, anti-cancer | [ |
| CaP scaffold with graphene oxide | Copper Nanocomposite | Angiogenesis, osteogenesis | [ |
| Ti–Cu sintered alloy | Ti–Cu sintered alloy | Antibacterial | [ |
| Calcium polyphosphate scaffolds | copper carbonate | Osteogenesis, angiogenesis, improvement of mechanical strength | [ |
| Alginate hydrogels | CuSO4 | Chondrogenesis, antibacterial | [ |
| Cylindrical collagen-based scaffold. | CuSO4 | Angiogenesis | [ |
| Bio-composite scaffolds | Cu–Zn alloy nanoparticles | Osteogenesis, antibacterial, porosity | [ |
| Carboxymethyl Chitosan/Alginate Scaffolds | Cu Nanoparticles | Osteogenesis, antibacterial, angiogenesis, auxiliary cross-linking | [ |
| PDLLA scaffolds with Cu- and Zn-doped bioactive glasses | CuO | Osteogenesis, angiogenesis, antibacterial | [ |
| Copper-bearing stainless steel | Cu-SS alloy | Osteogenesis, cell adhesion, biocompatibility, anti-inflammatory | [ |
| Calcium phosphate cement | Cu-TCP powders | Osteogenesis, angiogenesis, osteogenic differentiation of BMSCs | [ |
Fig. 3Scanning electron microscopy micrographs of scaffolds without and with copper nanoparticles: (a) 50% chitosan + 50% Gelatin +0% copper, (b) 25% chitosan + 75% Gelatin +0% copper, (c) 75% chitosan + 25% Gelatin +0% copper, (d) 50% chitosan + 50% Gelatin +0.01% copper, (e) 25% chitosan + 75% Gelatin +0.02% copper, (f) 75% chitosan + 25% Gelatin +0.03% copper.
Fig. 4Histological analysis of newly formed bone tissues. (a) Eight weeks after surgery, the longitudinal sections were imaged to display the new bones, shown as green lines, in the defect regions. Blue arrows indicate blood vessels perfused with Microfil. (b) The statistics of the blood vessels number (n = 6; ∗∗represents p < 0.01). (c) The statistics of the percentage of new bone area in the defect regions (n = 6; ∗∗represents p < 0.01).
Fig. 5The gross morphology and Micro-computed tomography images of the samples at 8 and 12 weeks of post-surgery (A1-F1) Digital photographs of the samples (A2-F2) 2-dimensional projection images of the defects (A3-F3) and (A4-F4) show the transverse view and sagittal view of 3-dimensional (3D) reconstruction images, respectively (A5-F5) Images of new bone in the upper part of the defects. In 3D reconstruction images, off-white, green, and red indicate primary bone, new bone, and scaffolds, respectively. As compared with control group and bioactive glass ceramic (BGC) groups, Cu-BGC group displayed a considerable amount of neo-bone tissue in the defect region at 12 weeks.